[
    {
        "id": 4084,
        "drug_name": "APHEXDA (motixafortide) in combination with filgrastim (G-CSF)",
        "clinical_trial_id": "NCT03246529",
        "has_trial_insight_page": 0,
        "indication": "Stem-cell mobilization for autologous transplantation",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-11",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BLRX\/news\/157855",
        "note": "FDA Approved on September 11, 2023.",
        "company_entity_id": 67,
        "company_ticker": "BLRX",
        "company_name": "BioLineRx Ltd.",
        "company_price": "1.1500",
        "company_change": 0.01,
        "company_percent_change": 0.88,
        "company_optionable": 1,
        "company_number_of_shares": 61530596,
        "price_change_sparkline": [
            [
                1.19,
                1706677200
            ],
            [
                1.16,
                1706763600
            ],
            [
                1.14,
                1706850000
            ],
            [
                1.11,
                1707109200
            ],
            [
                1.11,
                1707195600
            ],
            [
                1.095,
                1707282000
            ],
            [
                1.07,
                1707368400
            ],
            [
                1.09,
                1707454800
            ],
            [
                1.14,
                1707714000
            ],
            [
                1.105,
                1707800400
            ],
            [
                1.1,
                1707886800
            ],
            [
                1.105,
                1707973200
            ],
            [
                1.25,
                1708059600
            ],
            [
                1.21,
                1708405200
            ],
            [
                1.15,
                1708491600
            ],
            [
                1.24,
                1708578000
            ],
            [
                1.18,
                1708664400
            ],
            [
                1.26,
                1708923600
            ],
            [
                1.23,
                1709010000
            ],
            [
                1.32,
                1709096400
            ],
            [
                1.33,
                1709182800
            ],
            [
                1.33,
                1709269200
            ],
            [
                1.35,
                1709528400
            ],
            [
                1.33,
                1709614800
            ],
            [
                1.27,
                1709701200
            ],
            [
                1.2366,
                1709787600
            ],
            [
                1.18,
                1709874000
            ],
            [
                1.14,
                1710129600
            ],
            [
                1.15,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 8901,
        "drug_name": "Comirnaty (BNT162b2, XBB.1.5, BA.2.86 (Pirola), and EG.5.1 (Eris))",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "COVID-19 Vaccine (Omicron Booster)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-11",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/158010",
        "note": "FDA booster approved on September 11, 2023.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 8901,
        "drug_name": "Comirnaty (BNT162b2, XBB.1.5, BA.2.86 (Pirola), and EG.5.1 (Eris))",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "COVID-19 Vaccine (Omicron Booster)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-11",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/158010",
        "note": "FDA booster approved on September 11, 2023.",
        "company_entity_id": 707,
        "company_ticker": "BNTX",
        "company_name": "BioNTech SE",
        "company_price": "95.7300",
        "company_change": -0.5700000000000001,
        "company_percent_change": -0.5900000000000001,
        "company_optionable": 1,
        "company_number_of_shares": 240993998,
        "price_change_sparkline": [
            [
                95.04,
                1706677200
            ],
            [
                94.51,
                1706763600
            ],
            [
                92.65,
                1706850000
            ],
            [
                93.35,
                1707109200
            ],
            [
                96,
                1707195600
            ],
            [
                95.05,
                1707282000
            ],
            [
                94.1,
                1707368400
            ],
            [
                93.14,
                1707454800
            ],
            [
                93.86,
                1707714000
            ],
            [
                90.58,
                1707800400
            ],
            [
                91.46,
                1707886800
            ],
            [
                92.91,
                1707973200
            ],
            [
                91.67,
                1708059600
            ],
            [
                91.24,
                1708405200
            ],
            [
                92.74,
                1708491600
            ],
            [
                93.57,
                1708578000
            ],
            [
                93.97,
                1708664400
            ],
            [
                93.52,
                1708923600
            ],
            [
                92.79,
                1709010000
            ],
            [
                91.43,
                1709096400
            ],
            [
                88.96,
                1709182800
            ],
            [
                90.94,
                1709269200
            ],
            [
                89.3,
                1709528400
            ],
            [
                90.52,
                1709614800
            ],
            [
                91.39,
                1709701200
            ],
            [
                91.09,
                1709787600
            ],
            [
                91.27,
                1709874000
            ],
            [
                96.3,
                1710129600
            ],
            [
                95.73,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 8817,
        "drug_name": "mRNA-1273.222 - (including EG.5, FL.1.5.1, and BA.2.86)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Covid-19 Omicron Booster",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-11",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/MRNA\/news\/158013",
        "note": "FDA approved on September 11, 2023.",
        "company_entity_id": 618,
        "company_ticker": "MRNA",
        "company_name": "Moderna Inc.",
        "company_price": "110.4300",
        "company_change": -1.55,
        "company_percent_change": -1.38,
        "company_optionable": 1,
        "company_number_of_shares": 382073208,
        "price_change_sparkline": [
            [
                101.05,
                1706677200
            ],
            [
                99.02,
                1706763600
            ],
            [
                97.5,
                1706850000
            ],
            [
                95.49,
                1707109200
            ],
            [
                100.03,
                1707195600
            ],
            [
                99.3,
                1707282000
            ],
            [
                93.66,
                1707368400
            ],
            [
                87.41,
                1707454800
            ],
            [
                89,
                1707714000
            ],
            [
                85.37,
                1707800400
            ],
            [
                85.95,
                1707886800
            ],
            [
                91.14,
                1707973200
            ],
            [
                88.37,
                1708059600
            ],
            [
                86.99,
                1708405200
            ],
            [
                87.59,
                1708491600
            ],
            [
                99.44,
                1708578000
            ],
            [
                96.46,
                1708664400
            ],
            [
                94.02,
                1708923600
            ],
            [
                96.2,
                1709010000
            ],
            [
                97.48,
                1709096400
            ],
            [
                92.24,
                1709182800
            ],
            [
                95.06,
                1709269200
            ],
            [
                96,
                1709528400
            ],
            [
                95.56,
                1709614800
            ],
            [
                98.1,
                1709701200
            ],
            [
                99.48,
                1709787600
            ],
            [
                103.03,
                1709874000
            ],
            [
                111.98,
                1710129600
            ],
            [
                110.43,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10668,
        "drug_name": "Estradiol Tablets USP - (Estrace generic)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Menopause symptoms",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-12",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ANIP\/news\/158128",
        "note": "Approved September 12, 2023.",
        "company_entity_id": 792,
        "company_ticker": "ANIP",
        "company_name": "ANI Pharmaceuticals Inc.",
        "company_price": "66.5400",
        "company_change": 0.41,
        "company_percent_change": 0.62,
        "company_optionable": 1,
        "company_number_of_shares": 21078986,
        "price_change_sparkline": [
            [
                55.82,
                1706677200
            ],
            [
                56.51,
                1706763600
            ],
            [
                55.42,
                1706850000
            ],
            [
                56.04,
                1707109200
            ],
            [
                56.87,
                1707195600
            ],
            [
                56.03,
                1707282000
            ],
            [
                55.91,
                1707368400
            ],
            [
                56.51,
                1707454800
            ],
            [
                57.03,
                1707714000
            ],
            [
                55.02,
                1707800400
            ],
            [
                56.1,
                1707886800
            ],
            [
                57.55,
                1707973200
            ],
            [
                59.72,
                1708059600
            ],
            [
                58.37,
                1708405200
            ],
            [
                57.63,
                1708491600
            ],
            [
                58.15,
                1708578000
            ],
            [
                59.13,
                1708664400
            ],
            [
                60.25,
                1708923600
            ],
            [
                59.94,
                1709010000
            ],
            [
                60.28,
                1709096400
            ],
            [
                67.67,
                1709182800
            ],
            [
                67.17,
                1709269200
            ],
            [
                66.42,
                1709528400
            ],
            [
                65.34,
                1709614800
            ],
            [
                65.81,
                1709701200
            ],
            [
                66.71,
                1709787600
            ],
            [
                67.42,
                1709874000
            ],
            [
                66.13,
                1710129600
            ],
            [
                66.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5210,
        "drug_name": "Ojjaara (momelotinib)",
        "clinical_trial_id": "NCT04173494",
        "has_trial_insight_page": 0,
        "indication": "Myelofibrosis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-15",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/GSK\/news\/159079",
        "note": "Approved September 15, 2023.",
        "company_entity_id": 379,
        "company_ticker": "GSK",
        "company_name": "GSK plc American Depositary Shares (Each representing two)",
        "company_price": "43.2700",
        "company_change": 0.35,
        "company_percent_change": 0.82,
        "company_optionable": 1,
        "company_number_of_shares": 2058516719,
        "price_change_sparkline": [
            [
                39.0637603938206,
                1706677200
            ],
            [
                40.2424083367376,
                1706763600
            ],
            [
                40.3315497777986,
                1706850000
            ],
            [
                41.1734411655964,
                1707109200
            ],
            [
                41.3517240477183,
                1707195600
            ],
            [
                41.6191483709012,
                1707282000
            ],
            [
                41.4210562796546,
                1707368400
            ],
            [
                41.5101977207156,
                1707454800
            ],
            [
                40.67821093748,
                1707714000
            ],
            [
                40.9951582834745,
                1707800400
            ],
            [
                41.40124707053,
                1707886800
            ],
            [
                41.371533256843,
                1707973200
            ],
            [
                41.5399115344025,
                1708059600
            ],
            [
                41.6191483709012,
                1708405200
            ],
            [
                41.5399115344025,
                1708491600
            ],
            [
                42.16,
                1708578000
            ],
            [
                42.22,
                1708664400
            ],
            [
                42.34,
                1708923600
            ],
            [
                42.38,
                1709010000
            ],
            [
                42.34,
                1709096400
            ],
            [
                41.9,
                1709182800
            ],
            [
                42.03,
                1709269200
            ],
            [
                42.44,
                1709528400
            ],
            [
                42.6,
                1709614800
            ],
            [
                42.62,
                1709701200
            ],
            [
                43.58,
                1709787600
            ],
            [
                43.14,
                1709874000
            ],
            [
                42.92,
                1710129600
            ],
            [
                43.27,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3749,
        "drug_name": "TALICIA (RHB-105)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "H. pylori",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-18",
        "link": "FDA addtional Supplemental approval allowing a change to a more flexible three times daily, noted September 18, 2023.",
        "note": "https:\/\/www.biopharmcatalyst.com\/company\/RDHL\/news\/159168",
        "company_entity_id": 259,
        "company_ticker": "RDHL",
        "company_name": "Redhill Biopharma Ltd.",
        "company_price": "0.5443",
        "company_change": -0.010000000000000009,
        "company_percent_change": -1,
        "company_optionable": 0,
        "company_number_of_shares": 29703027,
        "price_change_sparkline": [
            [
                0.58,
                1706677200
            ],
            [
                0.5988,
                1706763600
            ],
            [
                0.57,
                1706850000
            ],
            [
                0.5299,
                1707109200
            ],
            [
                0.5145,
                1707195600
            ],
            [
                0.5437,
                1707282000
            ],
            [
                0.5321,
                1707368400
            ],
            [
                0.5958,
                1707454800
            ],
            [
                0.5808,
                1707714000
            ],
            [
                0.566,
                1707800400
            ],
            [
                0.557,
                1707886800
            ],
            [
                0.5437,
                1707973200
            ],
            [
                0.5506,
                1708059600
            ],
            [
                0.5272,
                1708405200
            ],
            [
                0.5523,
                1708491600
            ],
            [
                0.54,
                1708578000
            ],
            [
                0.5374,
                1708664400
            ],
            [
                0.5286,
                1708923600
            ],
            [
                0.5292,
                1709010000
            ],
            [
                0.539899,
                1709096400
            ],
            [
                0.616,
                1709182800
            ],
            [
                0.5652,
                1709269200
            ],
            [
                0.5999,
                1709528400
            ],
            [
                0.555,
                1709614800
            ],
            [
                0.5632,
                1709701200
            ],
            [
                0.533,
                1709787600
            ],
            [
                0.53504,
                1709874000
            ],
            [
                0.55,
                1710129600
            ],
            [
                0.5443,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9103,
        "drug_name": "Jardiance (empagliflozin) - (EMPA-KIDNEY)",
        "clinical_trial_id": "NCT03594110",
        "has_trial_insight_page": 1,
        "indication": "Chronic kidney disease (CKD)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-22",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LLY\/news\/160321",
        "note": "FDA Approval on September 22, 2023.",
        "company_entity_id": 382,
        "company_ticker": "LLY",
        "company_name": "Eli Lilly and Company",
        "company_price": "754.9500",
        "company_change": 20.58,
        "company_percent_change": 2.8,
        "company_optionable": 1,
        "company_number_of_shares": 950164452,
        "price_change_sparkline": [
            [
                644.503643637706,
                1706677200
            ],
            [
                659.298247188938,
                1706763600
            ],
            [
                666.505874560051,
                1706850000
            ],
            [
                704.989812947364,
                1707109200
            ],
            [
                703.821817930162,
                1707195600
            ],
            [
                724.13694493877,
                1707282000
            ],
            [
                734.41929423551,
                1707368400
            ],
            [
                738.891617036422,
                1707454800
            ],
            [
                735.996586651903,
                1707714000
            ],
            [
                741.696801650387,
                1707800400
            ],
            [
                757.31,
                1707886800
            ],
            [
                757.78,
                1707973200
            ],
            [
                782.06,
                1708059600
            ],
            [
                755.66,
                1708405200
            ],
            [
                745.91,
                1708491600
            ],
            [
                769.64,
                1708578000
            ],
            [
                769.54,
                1708664400
            ],
            [
                771.92,
                1708923600
            ],
            [
                765,
                1709010000
            ],
            [
                757.64,
                1709096400
            ],
            [
                753.68,
                1709182800
            ],
            [
                782.12,
                1709269200
            ],
            [
                792.28,
                1709528400
            ],
            [
                777.59,
                1709614800
            ],
            [
                779.77,
                1709701200
            ],
            [
                780.16,
                1709787600
            ],
            [
                762.14,
                1709874000
            ],
            [
                734.37,
                1710129600
            ],
            [
                754.95,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10497,
        "drug_name": "LIKMEZ (ATI-1501) - (liquid oral reformulation)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Parasitic and anaerobic bacterial infections",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-25",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/APLIF\/news\/160509",
        "note": "Approved September 25, 2023.",
        "company_entity_id": 2260,
        "company_ticker": "APLIF",
        "company_name": "Appili Therapeutics Inc",
        "company_price": "0.0230",
        "company_change": 0,
        "company_percent_change": 0,
        "company_optionable": 0,
        "company_number_of_shares": 121266120,
        "price_change_sparkline": [
            [
                0.0207,
                1706677200
            ],
            [
                0.0207,
                1706763600
            ],
            [
                0.0207,
                1706850000
            ],
            [
                0.0207,
                1707109200
            ],
            [
                0.0207,
                1707195600
            ],
            [
                0.0202,
                1707282000
            ],
            [
                0.0207,
                1707368400
            ],
            [
                0.0196,
                1707454800
            ],
            [
                0.0186,
                1707714000
            ],
            [
                0.01905,
                1707800400
            ],
            [
                0.018,
                1707886800
            ],
            [
                0.0223,
                1707973200
            ],
            [
                0.0186,
                1708059600
            ],
            [
                0.0162,
                1708405200
            ],
            [
                0.022,
                1708491600
            ],
            [
                0.022,
                1708578000
            ],
            [
                0.0187,
                1708664400
            ],
            [
                0.0217,
                1708923600
            ],
            [
                0.02035,
                1709010000
            ],
            [
                0.0194,
                1709096400
            ],
            [
                0.0217,
                1709182800
            ],
            [
                0.0265,
                1709269200
            ],
            [
                0.0258,
                1709528400
            ],
            [
                0.0222,
                1709614800
            ],
            [
                0.023,
                1709701200
            ],
            [
                0.023,
                1709787600
            ],
            [
                0.023,
                1709874000
            ],
            [
                0.023,
                1710129600
            ],
            [
                0.023,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7587,
        "drug_name": "RYZUMVI",
        "clinical_trial_id": "NCT05134974",
        "has_trial_insight_page": 0,
        "indication": "Mydriasis (RM)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-27",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/VTRS\/news\/161032",
        "note": "FDA Approval on  September 27, 2023.",
        "company_entity_id": 851,
        "company_ticker": "VTRS",
        "company_name": "Viatris Inc.",
        "company_price": "12.0600",
        "company_change": 0.09,
        "company_percent_change": 0.75,
        "company_optionable": 1,
        "company_number_of_shares": 1187569149,
        "price_change_sparkline": [
            [
                11.6559127625202,
                1706677200
            ],
            [
                11.754943457189,
                1706763600
            ],
            [
                11.7351373182553,
                1706850000
            ],
            [
                11.4677544426494,
                1707109200
            ],
            [
                11.7747495961228,
                1707195600
            ],
            [
                11.6262035541195,
                1707282000
            ],
            [
                11.4479483037157,
                1707368400
            ],
            [
                11.5667851373183,
                1707454800
            ],
            [
                11.8341680129241,
                1707714000
            ],
            [
                11.8539741518578,
                1707800400
            ],
            [
                11.9530048465267,
                1707886800
            ],
            [
                12.6957350565428,
                1707973200
            ],
            [
                12.933408723748,
                1708059600
            ],
            [
                13.1116639741519,
                1708405200
            ],
            [
                13.1314701130856,
                1708491600
            ],
            [
                13.2305008077544,
                1708578000
            ],
            [
                13.3988529886914,
                1708664400
            ],
            [
                13.2998222940226,
                1708923600
            ],
            [
                13.101760904685,
                1709010000
            ],
            [
                12.1708723747981,
                1709096400
            ],
            [
                12.2500969305331,
                1709182800
            ],
            [
                12.4679644588045,
                1709269200
            ],
            [
                12.2401938610662,
                1709528400
            ],
            [
                12.1609693053312,
                1709614800
            ],
            [
                12.0817447495961,
                1709701200
            ],
            [
                12.2104846526656,
                1709787600
            ],
            [
                12.26,
                1709874000
            ],
            [
                11.97,
                1710129600
            ],
            [
                12.06,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7587,
        "drug_name": "RYZUMVI",
        "clinical_trial_id": "NCT05134974",
        "has_trial_insight_page": 0,
        "indication": "Mydriasis (RM)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-27",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/VTRS\/news\/161032",
        "note": "FDA Approval on  September 27, 2023.",
        "company_entity_id": 908,
        "company_ticker": "OCUP",
        "company_name": "Ocuphire Pharma Inc.",
        "company_price": "2.1400",
        "company_change": 0.05,
        "company_percent_change": 2.39,
        "company_optionable": 1,
        "company_number_of_shares": 48335220,
        "price_change_sparkline": [
            [
                2.62,
                1706677200
            ],
            [
                2.73,
                1706763600
            ],
            [
                2.65,
                1706850000
            ],
            [
                2.52,
                1707109200
            ],
            [
                2.58,
                1707195600
            ],
            [
                2.48,
                1707282000
            ],
            [
                2.52,
                1707368400
            ],
            [
                2.62,
                1707454800
            ],
            [
                2.66,
                1707714000
            ],
            [
                2.57,
                1707800400
            ],
            [
                2.6,
                1707886800
            ],
            [
                2.65,
                1707973200
            ],
            [
                2.63,
                1708059600
            ],
            [
                2.58,
                1708405200
            ],
            [
                2.45,
                1708491600
            ],
            [
                2.5,
                1708578000
            ],
            [
                2.5,
                1708664400
            ],
            [
                2.53,
                1708923600
            ],
            [
                2.64,
                1709010000
            ],
            [
                2.59,
                1709096400
            ],
            [
                2.535,
                1709182800
            ],
            [
                2.53,
                1709269200
            ],
            [
                2.47,
                1709528400
            ],
            [
                2.43,
                1709614800
            ],
            [
                2.42,
                1709701200
            ],
            [
                2.38,
                1709787600
            ],
            [
                1.99,
                1709874000
            ],
            [
                2.09,
                1710129600
            ],
            [
                2.14,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6622,
        "drug_name": "ENTYVIO (vedolizumab)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Ulcerative Colitis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-27",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TAK\/news\/161219",
        "note": "FDA Approved on September 27, 2023.",
        "company_entity_id": 751,
        "company_ticker": "TAK",
        "company_name": "Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1\/2 of a share of)",
        "company_price": "14.3700",
        "company_change": -0.19999999999999996,
        "company_percent_change": -1.37,
        "company_optionable": 1,
        "company_number_of_shares": 3137776702,
        "price_change_sparkline": [
            [
                14.6,
                1706677200
            ],
            [
                14.38,
                1706763600
            ],
            [
                14.28,
                1706850000
            ],
            [
                13.92,
                1707109200
            ],
            [
                14.16,
                1707195600
            ],
            [
                14.18,
                1707282000
            ],
            [
                14,
                1707368400
            ],
            [
                14.24,
                1707454800
            ],
            [
                14.31,
                1707714000
            ],
            [
                14.34,
                1707800400
            ],
            [
                14.54,
                1707886800
            ],
            [
                14.42,
                1707973200
            ],
            [
                14.62,
                1708059600
            ],
            [
                14.82,
                1708405200
            ],
            [
                14.74,
                1708491600
            ],
            [
                14.64,
                1708578000
            ],
            [
                14.62,
                1708664400
            ],
            [
                14.81,
                1708923600
            ],
            [
                14.84,
                1709010000
            ],
            [
                14.65,
                1709096400
            ],
            [
                14.59,
                1709182800
            ],
            [
                14.56,
                1709269200
            ],
            [
                14.48,
                1709528400
            ],
            [
                14.4,
                1709614800
            ],
            [
                14.69,
                1709701200
            ],
            [
                14.86,
                1709787600
            ],
            [
                14.77,
                1709874000
            ],
            [
                14.57,
                1710129600
            ],
            [
                14.37,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5358,
        "drug_name": "Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat)",
        "clinical_trial_id": "NCT03729362",
        "has_trial_insight_page": 0,
        "indication": "Pompe Disease",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-28",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/FOLD\/news\/161443",
        "note": "FDA Approved on September 28, 2023.",
        "company_entity_id": 144,
        "company_ticker": "FOLD",
        "company_name": "Amicus Therapeutics Inc.",
        "company_price": "11.7900",
        "company_change": -0.33999999999999997,
        "company_percent_change": -2.8,
        "company_optionable": 1,
        "company_number_of_shares": 295382614,
        "price_change_sparkline": [
            [
                12.43,
                1706677200
            ],
            [
                12.67,
                1706763600
            ],
            [
                12.44,
                1706850000
            ],
            [
                12.7,
                1707109200
            ],
            [
                12.98,
                1707195600
            ],
            [
                13,
                1707282000
            ],
            [
                13.33,
                1707368400
            ],
            [
                13.55,
                1707454800
            ],
            [
                13.77,
                1707714000
            ],
            [
                12.8,
                1707800400
            ],
            [
                13.18,
                1707886800
            ],
            [
                14,
                1707973200
            ],
            [
                13.76,
                1708059600
            ],
            [
                13.7,
                1708405200
            ],
            [
                13.56,
                1708491600
            ],
            [
                13.4,
                1708578000
            ],
            [
                13.53,
                1708664400
            ],
            [
                13.78,
                1708923600
            ],
            [
                13.85,
                1709010000
            ],
            [
                12.95,
                1709096400
            ],
            [
                12.82,
                1709182800
            ],
            [
                13.29,
                1709269200
            ],
            [
                13.46,
                1709528400
            ],
            [
                13.35,
                1709614800
            ],
            [
                12.6,
                1709701200
            ],
            [
                12.29,
                1709787600
            ],
            [
                12.3,
                1709874000
            ],
            [
                12.13,
                1710129600
            ],
            [
                11.79,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7874,
        "drug_name": "TOFIDENCE (tocilizumab-bavi) - (ACTEMRA biosimilar)",
        "clinical_trial_id": "NCT03830203",
        "has_trial_insight_page": 1,
        "indication": "Rheumatoid arthritis (RA)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-09-29",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BIIB\/news\/161715",
        "note": "FDA Biosimilar of  ACTEMRA approved on September 29, 2023.",
        "company_entity_id": 375,
        "company_ticker": "BIIB",
        "company_name": "Biogen Inc.",
        "company_price": "227.3600",
        "company_change": -2.71,
        "company_percent_change": -1.1800000000000002,
        "company_optionable": 1,
        "company_number_of_shares": 145360798,
        "price_change_sparkline": [
            [
                246.66,
                1706677200
            ],
            [
                247.83,
                1706763600
            ],
            [
                243.72,
                1706850000
            ],
            [
                241.84,
                1707109200
            ],
            [
                245.55,
                1707195600
            ],
            [
                240.54,
                1707282000
            ],
            [
                240.3,
                1707368400
            ],
            [
                240.98,
                1707454800
            ],
            [
                244.74,
                1707714000
            ],
            [
                226.65,
                1707800400
            ],
            [
                220.74,
                1707886800
            ],
            [
                223.35,
                1707973200
            ],
            [
                219.08,
                1708059600
            ],
            [
                219.21,
                1708405200
            ],
            [
                221.11,
                1708491600
            ],
            [
                222.48,
                1708578000
            ],
            [
                223.32,
                1708664400
            ],
            [
                223.71,
                1708923600
            ],
            [
                223.94,
                1709010000
            ],
            [
                221.74,
                1709096400
            ],
            [
                216.99,
                1709182800
            ],
            [
                220.95,
                1709269200
            ],
            [
                221.02,
                1709528400
            ],
            [
                217.23,
                1709614800
            ],
            [
                217.56,
                1709701200
            ],
            [
                219.36,
                1709787600
            ],
            [
                223.24,
                1709874000
            ],
            [
                230.07,
                1710129600
            ],
            [
                227.36,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6825,
        "drug_name": "Cortrophin Gel",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Acute exacerbations of multiple sclerosis, rheumatoid arthritis, systemic lupus erythematous and ulcerative colitis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-02",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ANIP\/news\/161851",
        "note": "1-ml vial approved October 2, 2023.",
        "company_entity_id": 792,
        "company_ticker": "ANIP",
        "company_name": "ANI Pharmaceuticals Inc.",
        "company_price": "66.5400",
        "company_change": 0.41,
        "company_percent_change": 0.62,
        "company_optionable": 1,
        "company_number_of_shares": 21078986,
        "price_change_sparkline": [
            [
                55.82,
                1706677200
            ],
            [
                56.51,
                1706763600
            ],
            [
                55.42,
                1706850000
            ],
            [
                56.04,
                1707109200
            ],
            [
                56.87,
                1707195600
            ],
            [
                56.03,
                1707282000
            ],
            [
                55.91,
                1707368400
            ],
            [
                56.51,
                1707454800
            ],
            [
                57.03,
                1707714000
            ],
            [
                55.02,
                1707800400
            ],
            [
                56.1,
                1707886800
            ],
            [
                57.55,
                1707973200
            ],
            [
                59.72,
                1708059600
            ],
            [
                58.37,
                1708405200
            ],
            [
                57.63,
                1708491600
            ],
            [
                58.15,
                1708578000
            ],
            [
                59.13,
                1708664400
            ],
            [
                60.25,
                1708923600
            ],
            [
                59.94,
                1709010000
            ],
            [
                60.28,
                1709096400
            ],
            [
                67.67,
                1709182800
            ],
            [
                67.17,
                1709269200
            ],
            [
                66.42,
                1709528400
            ],
            [
                65.34,
                1709614800
            ],
            [
                65.81,
                1709701200
            ],
            [
                66.71,
                1709787600
            ],
            [
                67.42,
                1709874000
            ],
            [
                66.13,
                1710129600
            ],
            [
                66.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 6056,
        "drug_name": "EMPAVELI (pegcetacoplan) injector",
        "clinical_trial_id": "NCT04085601",
        "has_trial_insight_page": 1,
        "indication": "Paroxysmal Nocturnal Hemoglobinuria (PNH)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-02",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/APLS\/news\/161856",
        "note": "FDA Approved on October 2, 2023.",
        "company_entity_id": 465,
        "company_ticker": "APLS",
        "company_name": "Apellis Pharmaceuticals Inc.",
        "company_price": "58.5000",
        "company_change": -2.19,
        "company_percent_change": -3.61,
        "company_optionable": 1,
        "company_number_of_shares": 120581749,
        "price_change_sparkline": [
            [
                63.29,
                1706677200
            ],
            [
                62.13,
                1706763600
            ],
            [
                62.56,
                1706850000
            ],
            [
                68.16,
                1707109200
            ],
            [
                67.31,
                1707195600
            ],
            [
                66.7,
                1707282000
            ],
            [
                68.12,
                1707368400
            ],
            [
                68.56,
                1707454800
            ],
            [
                67.75,
                1707714000
            ],
            [
                66.17,
                1707800400
            ],
            [
                67.39,
                1707886800
            ],
            [
                67.58,
                1707973200
            ],
            [
                68.78,
                1708059600
            ],
            [
                67.85,
                1708405200
            ],
            [
                66.89,
                1708491600
            ],
            [
                67.59,
                1708578000
            ],
            [
                68.47,
                1708664400
            ],
            [
                71.73,
                1708923600
            ],
            [
                69.35,
                1709010000
            ],
            [
                64.05,
                1709096400
            ],
            [
                61.97,
                1709182800
            ],
            [
                63.89,
                1709269200
            ],
            [
                64.63,
                1709528400
            ],
            [
                62.47,
                1709614800
            ],
            [
                60.94,
                1709701200
            ],
            [
                62.44,
                1709787600
            ],
            [
                61.63,
                1709874000
            ],
            [
                60.69,
                1710129600
            ],
            [
                58.5,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10723,
        "drug_name": "NVX-CoV2601 (Adjuvanted 2023-2024 Formula)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Covid-19",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-03",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/NVAX\/news\/162351",
        "note": "EUA approved October 3, 2023.",
        "company_entity_id": 215,
        "company_ticker": "NVAX",
        "company_name": "Novavax Inc.",
        "company_price": "5.0600",
        "company_change": -0.06999999999999995,
        "company_percent_change": -1.3599999999999999,
        "company_optionable": 1,
        "company_number_of_shares": 139953143,
        "price_change_sparkline": [
            [
                4,
                1706677200
            ],
            [
                4.02,
                1706763600
            ],
            [
                3.93,
                1706850000
            ],
            [
                3.76,
                1707109200
            ],
            [
                3.93,
                1707195600
            ],
            [
                3.78,
                1707282000
            ],
            [
                3.79,
                1707368400
            ],
            [
                4.03,
                1707454800
            ],
            [
                4.15,
                1707714000
            ],
            [
                3.9,
                1707800400
            ],
            [
                4.1,
                1707886800
            ],
            [
                4.3,
                1707973200
            ],
            [
                4.16,
                1708059600
            ],
            [
                4.13,
                1708405200
            ],
            [
                3.98,
                1708491600
            ],
            [
                4.88,
                1708578000
            ],
            [
                5.29,
                1708664400
            ],
            [
                5.5,
                1708923600
            ],
            [
                6.02,
                1709010000
            ],
            [
                4.41,
                1709096400
            ],
            [
                4.94,
                1709182800
            ],
            [
                5.39,
                1709269200
            ],
            [
                5.49,
                1709528400
            ],
            [
                5.57,
                1709614800
            ],
            [
                5.61,
                1709701200
            ],
            [
                5.61,
                1709787600
            ],
            [
                5.45,
                1709874000
            ],
            [
                5.13,
                1710129600
            ],
            [
                5.06,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10056,
        "drug_name": "ZORYVE (roflumilast) cream",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Plaque psoriasis in children",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-06",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ARQT\/news\/162959",
        "note": "Approved for treatment of children aged 6 - 11 on October 6, 2023.",
        "company_entity_id": 738,
        "company_ticker": "ARQT",
        "company_name": "Arcutis Biotherapeutics Inc.",
        "company_price": "10.1100",
        "company_change": 0.07,
        "company_percent_change": 0.7,
        "company_optionable": 1,
        "company_number_of_shares": 96813363,
        "price_change_sparkline": [
            [
                5.87,
                1706677200
            ],
            [
                6.64,
                1706763600
            ],
            [
                6.07,
                1706850000
            ],
            [
                6.02,
                1707109200
            ],
            [
                5.7,
                1707195600
            ],
            [
                5.71,
                1707282000
            ],
            [
                5.7,
                1707368400
            ],
            [
                6.57,
                1707454800
            ],
            [
                6.69,
                1707714000
            ],
            [
                6.9,
                1707800400
            ],
            [
                7.58,
                1707886800
            ],
            [
                7.97,
                1707973200
            ],
            [
                9.3,
                1708059600
            ],
            [
                9.48,
                1708405200
            ],
            [
                9.27,
                1708491600
            ],
            [
                9.62,
                1708578000
            ],
            [
                9.68,
                1708664400
            ],
            [
                9.69,
                1708923600
            ],
            [
                10.63,
                1709010000
            ],
            [
                10.41,
                1709096400
            ],
            [
                10.28,
                1709182800
            ],
            [
                11.77,
                1709269200
            ],
            [
                10.95,
                1709528400
            ],
            [
                10.9,
                1709614800
            ],
            [
                10.44,
                1709701200
            ],
            [
                10.38,
                1709787600
            ],
            [
                11.15,
                1709874000
            ],
            [
                10.04,
                1710129600
            ],
            [
                10.11,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10735,
        "drug_name": "Ameluz (aminolevulinic acid hydrochloride) - (New formula)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Actinic keratosis (AK)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-10",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BFRI\/news\/163454",
        "note": "Approved October 10, 2023.",
        "company_entity_id": 1019,
        "company_ticker": "BFRI",
        "company_name": "Biofrontera Inc.",
        "company_price": "1.3100",
        "company_change": 0.1,
        "company_percent_change": 8.26,
        "company_optionable": 0,
        "company_number_of_shares": 1517628,
        "price_change_sparkline": [
            [
                1.33,
                1706677200
            ],
            [
                1.335,
                1706763600
            ],
            [
                0.92,
                1706850000
            ],
            [
                0.94,
                1707109200
            ],
            [
                0.893,
                1707195600
            ],
            [
                0.7155,
                1707282000
            ],
            [
                0.729,
                1707368400
            ],
            [
                0.7316,
                1707454800
            ],
            [
                0.71,
                1707714000
            ],
            [
                0.6996,
                1707800400
            ],
            [
                0.684,
                1707886800
            ],
            [
                0.6937,
                1707973200
            ],
            [
                0.7495,
                1708059600
            ],
            [
                1.15,
                1708405200
            ],
            [
                0.977,
                1708491600
            ],
            [
                0.995,
                1708578000
            ],
            [
                0.92,
                1708664400
            ],
            [
                0.8926,
                1708923600
            ],
            [
                0.8694,
                1709010000
            ],
            [
                0.813,
                1709096400
            ],
            [
                0.8377,
                1709182800
            ],
            [
                0.892,
                1709269200
            ],
            [
                0.9,
                1709528400
            ],
            [
                0.88,
                1709614800
            ],
            [
                0.941,
                1709701200
            ],
            [
                1.19,
                1709787600
            ],
            [
                1.22,
                1709874000
            ],
            [
                1.21,
                1710129600
            ],
            [
                1.31,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9268,
        "drug_name": "BRAFTOVI (Encorafenib) + MEKTOVI (\u200bbinimetinib)",
        "clinical_trial_id": "NCT03915951",
        "has_trial_insight_page": 0,
        "indication": "BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-12",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/163894",
        "note": "Approved October 12, 2023.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3928,
        "drug_name": "VELSIPITY (etrasimod)",
        "clinical_trial_id": "NCT03945188",
        "has_trial_insight_page": 1,
        "indication": "Ulcerative colitis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-13",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/PFE\/news\/164212",
        "note": "FDA Approved on October 13, 2023.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9794,
        "drug_name": "OPDIVO (nivolumab) - (Checkmate-76k)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Stage IIB or IIC melanoma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/BMY\/news\/119423",
        "note": "Approved October 13, 2023.",
        "company_entity_id": 376,
        "company_ticker": "BMY",
        "company_name": "Bristol-Myers Squibb Company",
        "company_price": "54.4000",
        "company_change": 0.04,
        "company_percent_change": 0.07,
        "company_optionable": 1,
        "company_number_of_shares": 2022193411,
        "price_change_sparkline": [
            [
                48.87,
                1706677200
            ],
            [
                48.67,
                1706763600
            ],
            [
                48.71,
                1706850000
            ],
            [
                47.98,
                1707109200
            ],
            [
                49.26,
                1707195600
            ],
            [
                48.64,
                1707282000
            ],
            [
                48.71,
                1707368400
            ],
            [
                49.81,
                1707454800
            ],
            [
                49.75,
                1707714000
            ],
            [
                48.71,
                1707800400
            ],
            [
                48.89,
                1707886800
            ],
            [
                49.44,
                1707973200
            ],
            [
                49.86,
                1708059600
            ],
            [
                49.86,
                1708405200
            ],
            [
                50.91,
                1708491600
            ],
            [
                51.33,
                1708578000
            ],
            [
                51.66,
                1708664400
            ],
            [
                50.52,
                1708923600
            ],
            [
                50.51,
                1709010000
            ],
            [
                50.92,
                1709096400
            ],
            [
                50.75,
                1709182800
            ],
            [
                50.89,
                1709269200
            ],
            [
                50.92,
                1709528400
            ],
            [
                51.82,
                1709614800
            ],
            [
                53.38,
                1709701200
            ],
            [
                53.28,
                1709787600
            ],
            [
                53.79,
                1709874000
            ],
            [
                54.36,
                1710129600
            ],
            [
                54.4,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10216,
        "drug_name": "KEYTRUDA (pembrolizumab) in combination with chemotherapy",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Resectable Stage II, IIIA or IIIB Non-Small Cell Lung Cancer (NSCLC)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/MRK\/news\/164592",
        "note": "Approved on October 16, 2023.",
        "company_entity_id": 383,
        "company_ticker": "MRK",
        "company_name": "Merck & Company Inc.",
        "company_price": "122.6600",
        "company_change": -0.10999999999999999,
        "company_percent_change": -0.08999999999999997,
        "company_optionable": 1,
        "company_number_of_shares": 2532643872,
        "price_change_sparkline": [
            [
                120.78,
                1706677200
            ],
            [
                126.38,
                1706763600
            ],
            [
                126.41,
                1706850000
            ],
            [
                126.18,
                1707109200
            ],
            [
                126.88,
                1707195600
            ],
            [
                127.47,
                1707282000
            ],
            [
                126.61,
                1707368400
            ],
            [
                125.45,
                1707454800
            ],
            [
                125.34,
                1707714000
            ],
            [
                125.43,
                1707800400
            ],
            [
                125.82,
                1707886800
            ],
            [
                126.54,
                1707973200
            ],
            [
                127.79,
                1708059600
            ],
            [
                127.37,
                1708405200
            ],
            [
                128.12,
                1708491600
            ],
            [
                129.26,
                1708578000
            ],
            [
                129.45,
                1708664400
            ],
            [
                128.84,
                1708923600
            ],
            [
                129.03,
                1709010000
            ],
            [
                128.19,
                1709096400
            ],
            [
                127.15,
                1709182800
            ],
            [
                126.96,
                1709269200
            ],
            [
                124.05,
                1709528400
            ],
            [
                122.83,
                1709614800
            ],
            [
                123.75,
                1709701200
            ],
            [
                123.99,
                1709787600
            ],
            [
                123.5,
                1709874000
            ],
            [
                122.77,
                1710129600
            ],
            [
                122.66,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4123,
        "drug_name": "XPHOZAH (tenapanor)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Serum phosphorus - chronic kidney disease (CKD) on dialysis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-10-17",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ARDX\/news\/164820",
        "note": "Approved October 17, 2023.",
        "company_entity_id": 41,
        "company_ticker": "ARDX",
        "company_name": "Ardelyx Inc.",
        "company_price": "8.4200",
        "company_change": -0.06999999999999995,
        "company_percent_change": -0.8200000000000001,
        "company_optionable": 1,
        "company_number_of_shares": 232686008,
        "price_change_sparkline": [
            [
                8.73,
                1706677200
            ],
            [
                9.29,
                1706763600
            ],
            [
                8.89,
                1706850000
            ],
            [
                8.96,
                1707109200
            ],
            [
                9.12,
                1707195600
            ],
            [
                8.97,
                1707282000
            ],
            [
                9.27,
                1707368400
            ],
            [
                9.74,
                1707454800
            ],
            [
                9.73,
                1707714000
            ],
            [
                8.86,
                1707800400
            ],
            [
                9.28,
                1707886800
            ],
            [
                9.3,
                1707973200
            ],
            [
                9.04,
                1708059600
            ],
            [
                8.55,
                1708405200
            ],
            [
                8.5,
                1708491600
            ],
            [
                8.82,
                1708578000
            ],
            [
                8.68,
                1708664400
            ],
            [
                9.29,
                1708923600
            ],
            [
                9.67,
                1709010000
            ],
            [
                9.46,
                1709096400
            ],
            [
                9.32,
                1709182800
            ],
            [
                9.34,
                1709269200
            ],
            [
                9.04,
                1709528400
            ],
            [
                9.59,
                1709614800
            ],
            [
                9.53,
                1709701200
            ],
            [
                8.97,
                1709787600
            ],
            [
                8.69,
                1709874000
            ],
            [
                8.49,
                1710129600
            ],
            [
                8.42,
                1710216000
            ]
        ],
        "statuses": []
    }
]